These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
78 related items for PubMed ID: 6973504
1. [Modified E rosette test in patients with malignant ovarian neoplasms]. Simm S, Tomaszkiewicz T, Markowska J, Kominek P. Ginekol Pol; 1981 Mar; 52(3):225-30. PubMed ID: 6973504 [No Abstract] [Full Text] [Related]
2. [Study of humoral and cellular immunity in the course of ovarian carcinoma]. Laghi V, Carella G, Burrai I, Sacco F, Margariti PA, Villani L, Benedetti Panici P. Minerva Ginecol; 1979 Oct 10; 31(10):737-46. PubMed ID: 317512 [No Abstract] [Full Text] [Related]
4. Cellular immunologic responsiveness to extracts of ovarian epithelial tumors. Melnick H, Barber HR. Gynecol Oncol; 1975 Mar 10; 3(1):77-86. PubMed ID: 168133 [No Abstract] [Full Text] [Related]
5. Serum and tissue measurements of CA72-4 in ovarian cancer patients. Negishi Y, Iwabuchi H, Sakunaga H, Sakamoto M, Okabe K, Sato H, Asano G. Gynecol Oncol; 1993 Feb 10; 48(2):148-54. PubMed ID: 8381375 [Abstract] [Full Text] [Related]
6. [Immunity in patients with malignant ovarian neoplasms]. Markowska J, Tomaszkiewicz T, Simm S, Jankowiak S. Ginekol Pol; 1981 Aug 10; 52(8):729-37. PubMed ID: 6975740 [No Abstract] [Full Text] [Related]
10. [Correlation of skin tests with the peripheral blood T- and B-lymphocyte tests in malignant ovarian tumors]. Markowska J, Tomaszkiewicz T, Simm S. Ginekol Pol; 1980 Aug 10; 51(8):731-6. PubMed ID: 6968703 [No Abstract] [Full Text] [Related]
11. Preliminary studies on the effect of Ukrain (Tris(2-([5bS-(5ba,6b,12ba)]- 5b,6,7,12b,13,14-hexahydro-13-methyl[1,3] benzodioxolo[5,6-v]-1-3- dioxolo[4,5-i]phenanthridinium-6-ol]-Ethaneaminyl)Phosphinesulfide.6HCl ) on the immunological response in patients with malignant tumours. Danilos J, Zbroja-Sontag W, Baran E, Kurylcio L, Kondratowicz L, Jusiak L. Drugs Exp Clin Res; 1992 Aug 10; 18 Suppl():55-62. PubMed ID: 1305046 [Abstract] [Full Text] [Related]
13. [Changes in the immune status of patients with cancer of the female genitalia]. Kis'ov V. Akush Ginekol (Sofiia); 1991 Aug 10; 30(1):22-4. PubMed ID: 1793132 [Abstract] [Full Text] [Related]
15. [Immunologic aspects of ovarian tumors]. Makarov OV, Khashchukoeva AZ, Borisenko SA, Epeĭkina TN, Moiseeva NB. Akush Ginekol (Mosk); 1988 Nov 10; (11):3-6. PubMed ID: 3071162 [No Abstract] [Full Text] [Related]
16. [Indicators of cellular immunity in patients with ovarian cancer and methods of their correction]. Stambrovskaia AA, Siparov IN. Akush Ginekol (Mosk); 1987 Jul 10; (7):43-6. PubMed ID: 3688330 [No Abstract] [Full Text] [Related]
17. [Clinical usefulness of monoclonal antibody, CA 125 and CA 19-9 in ovarian cancer]. Saitoh S, Nakanishi A, Noda T, Ando Y, Katakami Y, Kiyozuka Y, Moriyama I, Ichijo M. Nihon Gan Chiryo Gakkai Shi; 1984 Dec 20; 19(10):2327-35. PubMed ID: 6598184 [No Abstract] [Full Text] [Related]